tirzepatide for heart failure with preserved ejection fraction and obesity VisualAbstract: Semaglutide in Patients with Obesity and Heart Failure With

Tirzepatide has a cardiovascular outcome trial (SURMOUNT-MMO) underway, with results expected in 2025 to 2026

Otherwise, patients may not know what dosage to take and end up over-medicating themselves

Can you inject Retatrutide into the same place every week

Recent clinical trials, published in September 2025 in The New England Journal of Medicine , show that high-dose oral semaglutide tablets can deliver weight loss results that begin to approach what we see with injections

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits

In simple terms, they can help you feel full faster, stay full longer, and think about food less